Scientific Advisory Board
Pepscan’s Scientific Advisory Board
Prof. Andrew Hamilton is the Vice-Chancellor of the University of Oxford since 2009. He is the former Provost of Yale and served as chairman of the department of chemistry at Yale. Hamilton obtained his PhD from Cambridge University and was assistant professor of Chemistry at Princeton University and professor of chemistry at the University of Pittsburgh. His research interests lie at the interface of organic and biological chemistry, with particular focus on the use of synthetic design for the understanding, mimicry, and potential disruption of biological processes. His lab is most noted for the design of barbiturate hosts, farnesyl tranferase inhibitors, protein surface binders, and helix mimetics.
Prof. Andreas Plückthun studied chemistry at the University of Heidelberg and obtained a PhD from the University of California San Diego. He worked as a postdoctoral fellow in the Chemistry Department of Harvard University. He was appointed as a Professor of Biochemistry in Zürich in 1993. His pioneering scientific work on antibody and protein engineering has made him one of the most highly cited scientists in protein science. His work has been honored by a number of international awards and membership of the German Academy of Science. In 1992, he co-founded the biotechnology company MorphoSys, currently a leading antibody company, and in 2004 he co-founded the biotech company Molecular Partners, which is located in Zurich.
Prof. Reinhold Förster is Professor of Immunology and Head of the Institute of Immunology at Hannover Medical School. He studied Veterinary Medicine in Munich and Cambridge (UK) and in 1991 obtained his PhD summa cum laude from the University of Munich. From 1991-1993, he worked at the GenCenter at Munich University starting his work on chemokines and their receptors. From 1994 to 2000 he worked at the Max-Delbrueck-Center for Molecular Medicine in Berlin and in 2000, he was appointed Associate Professor at the University of Erlangen. In 2001 he was appointed to his current position at MHH. Reinhold Förster is an internationally acknowledged expert on chemokines. Using gene targeting in mice he has published fundamental papers regarding the function of chemokine receptors such as CXCR5, CCR9 and CCR7.